Searched for
PHARMEASY VALUATION
FirstCry, Slice’s FY26 numbers; Nilekani’s Fundamentum eyes deeptech pushFirstCry parent cut its losses in the March quarter on tightened costs. This and more in today's ETtech Top 5.- PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
- Global asset manager Janus Henderson cuts PharmEasy valuation further to $2.7 billionAs of March 31, 2023, funds managed by Janus Henderson valued their stake in the startup at $2.7 billion – less than half of the $5.6 billi...
- US investor Janus Henderson cuts PharmEasy valuation by half to $2.8 billionThe global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, whi...
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy floats rights issue to raise Rs 750 croreThe company's existing investors like Prosus Ventures and Temasek as well as its founders have subscribed to the issue for shares worth abo...
- PharmEasy prepares Rs 750 crore funding through convertible notesProsus Ventures, Temasek and others participate; online pharmacy reconsidering external fundraise amid funding slowdown
- PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
- Sebi clears PharmEasy’s Rs 6,250 crore IPOMumbai-based API Holdings had filed its draft IPO papers in November to raise Rs 6,250 crore through a sale of primary shares. Existing sha...
- PharmEasy parent company gets Sebi nod for Rs 6,250-cr public offerAPI Holdings, the parent firm of PharmEasy, has got clearance from markets regulator Securities and Exchange Board of India for the online ...
- PharmEasy may have to rework IPO valuation as street mood swingsUnlike Delhivery and Oyo Hotels & Homes, its IPO is fully through primary share sale and doesn’t have an OFS (offer for sale) component. It...
- PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
- Ecomm sales boom in festive season; PharmEasy raises $350 millionFrom refrigerators to clothes, ecommerce firms accounted for a higher share of total sales than they did this time last year. Read on to fi...
- PharmEasy’s new backers, Facebook whistleblower revealedPharmEasy is in talks with a clutch of new investors, including two hedge funds, to join its pre-IPO funding round.
- Exclusive: New investors in talks to join PharmEasy’s pre-IPO funding roundThe company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder N...
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
- PharmEasy plans to file IPO papers by OctoberPharmEasy is on track for an IPO but is still negotiating with new investors to raise between $200 million and $300 million at a valuation ...
- PharmEasy valued at $1.8 billion as B Capital buys stake for $20 millionE-pharmacy conducts $3 million Esop buyback; Tiger Global also putting primary capital in Mumbai-based startup.
- Pharmeasy eyes IPO at $3 billion valuation, buys rival MedlifePharmeasy acquired smaller rival Medlife, in the largest consolidation deal in India's fast-growing online pharmacy sector
- Pharmeasy parent enters unicorn club at $1.5 billion valuationPharmeasy’s $350 million funding round comes at a time when Reliance, Tata Group and Amazon are looking to tap the online pharmacy business...
Load More
